{
  "id": [
    "27463372"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "27463372"
  ],
  "pmcid": [
    "PMC4963023"
  ],
  "doi": [
    "10.1371/journal.pone.0159716"
  ],
  "title": [
    "Targeting Tumor Cells with Anti-CD44 Antibody Triggers Macrophage-Mediated Immune Modulatory Effects in a Cancer Xenograft Model."
  ],
  "authorString": [
    "Maisel D, Birzele F, Voss E, Nopora A, Bader S, Friess T, Goller B, Laifenfeld D, Weigand S, Runza V."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Maisel D"
          ],
          "firstName": [
            "Daniela"
          ],
          "lastName": [
            "Maisel"
          ],
          "initials": [
            "D"
          ],
          "affiliation": [
            "Translational Technologies and Bioinformatics, Pharmaceutical Sciences, Roche Innovation Center Munich, Penzberg, Germany."
          ]
        },
        {
          "fullName": [
            "Birzele F"
          ],
          "firstName": [
            "Fabian"
          ],
          "lastName": [
            "Birzele"
          ],
          "initials": [
            "F"
          ],
          "affiliation": [
            "Translational Technologies and Bioinformatics, Pharmaceutical Sciences, Roche Innovation Center Munich, Penzberg, Germany."
          ]
        },
        {
          "fullName": [
            "Voss E"
          ],
          "firstName": [
            "Edgar"
          ],
          "lastName": [
            "Voss"
          ],
          "initials": [
            "E"
          ],
          "affiliation": [
            "Discovery Oncology, Roche Innovation Center Munich, Penzberg, Germany."
          ]
        },
        {
          "fullName": [
            "Nopora A"
          ],
          "firstName": [
            "Adam"
          ],
          "lastName": [
            "Nopora"
          ],
          "initials": [
            "A"
          ],
          "affiliation": [
            "Discovery Oncology, Roche Innovation Center Munich, Penzberg, Germany."
          ]
        },
        {
          "fullName": [
            "Bader S"
          ],
          "firstName": [
            "Sabine"
          ],
          "lastName": [
            "Bader"
          ],
          "initials": [
            "S"
          ],
          "affiliation": [
            "Translational Technologies and Bioinformatics, Pharmaceutical Sciences, Roche Innovation Center Munich, Penzberg, Germany."
          ]
        },
        {
          "fullName": [
            "Friess T"
          ],
          "firstName": [
            "Thomas"
          ],
          "lastName": [
            "Friess"
          ],
          "initials": [
            "T"
          ],
          "affiliation": [
            "Discovery Oncology, Roche Innovation Center Munich, Penzberg, Germany."
          ]
        },
        {
          "fullName": [
            "Goller B"
          ],
          "firstName": [
            "Bernhard"
          ],
          "lastName": [
            "Goller"
          ],
          "initials": [
            "B"
          ],
          "affiliation": [
            "Discovery Oncology, Roche Innovation Center Munich, Penzberg, Germany."
          ]
        },
        {
          "fullName": [
            "Laifenfeld D"
          ],
          "firstName": [
            "Daphna"
          ],
          "lastName": [
            "Laifenfeld"
          ],
          "initials": [
            "D"
          ],
          "affiliation": [
            "Selventa Inc., Cambridge, Massachusetts, 02140, United States of America."
          ]
        },
        {
          "fullName": [
            "Weigand S"
          ],
          "firstName": [
            "Stefan"
          ],
          "lastName": [
            "Weigand"
          ],
          "initials": [
            "S"
          ],
          "affiliation": [
            "Large Molecule Research, Roche Innovation Center Basel, Basel, Switzerland."
          ]
        },
        {
          "fullName": [
            "Runza V"
          ],
          "firstName": [
            "Valeria"
          ],
          "lastName": [
            "Runza"
          ],
          "initials": [
            "V"
          ],
          "affiliation": [
            "Discovery Oncology, Roche Innovation Center Munich, Penzberg, Germany."
          ]
        }
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "7"
      ],
      "volume": [
        "11"
      ],
      "journalIssueId": [
        "2424094"
      ],
      "dateOfPublication": [
        "2016"
      ],
      "monthOfPublication": [
        "0"
      ],
      "yearOfPublication": [
        "2016"
      ],
      "printPublicationDate": [
        "2016-01-01"
      ],
      "journal": [
        {
          "title": [
            "PloS one"
          ],
          "ISOAbbreviation": [
            "PLoS ONE"
          ],
          "medlineAbbreviation": [
            "PLoS One"
          ],
          "NLMid": [
            "101285081"
          ],
          "ESSN": [
            "1932-6203"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2016"
  ],
  "pageInfo": [
    "e0159716"
  ],
  "abstractText": [
    "CD44, a transmembrane receptor reported to be involved in various cellular functions, is overexpressed in several cancer types and supposed to be involved in the initiation, progression and prognosis of these cancers. Since the sequence of events following the blockage of the CD44-HA interaction has not yet been studied in detail, we profiled xenograft tumors by RNA Sequencing to elucidate the mode of action of the anti-CD44 antibody RG7356. Analysis of tumor and host gene-expression profiles led us to the hypothesis that treatment with RG7356 antibody leads to an activation of the immune system. Using cytokine measurements we further show that this activation involves the secretion of chemo-attractants necessary for the recruitment of immune cells (i.e. macrophages) to the tumor site. We finally provide evidence for antibody-dependent cellular phagocytosis (ADCP) of the malignant cells by macrophages."
  ],
  "affiliation": [
    "Translational Technologies and Bioinformatics, Pharmaceutical Sciences, Roche Innovation Center Munich, Penzberg, Germany."
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Electronic-eCollection"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "Journal Article"
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC4963023?pdf=render"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC4963023"
          ]
        },
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "http://dx.doi.org/10.1371/journal.pone.0159716"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "1"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "license": [
    "cc by"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCreation": [
    "2016-07-28"
  ],
  "dateOfRevision": [
    "2016-08-09"
  ],
  "electronicPublicationDate": [
    "2016-07-27"
  ],
  "firstPublicationDate": [
    "2016-07-27"
  ]
}